[Malignant central nervous system tumors are susceptible to specific antibodies].

Abstract	The binding of circulating specific IgG to glioblastoma cells from brain tumor biopsies was shown using fluorescence conjugate Protein A-FITC and Western blotting. Blood-brain barrier permeability for antitumor antibodies in vivo in glioblastoma patients is suggested.
Authors	O P Blizniukov, L D Kozmin, V E Oliushin, O V Ostreĭko, M V Filatov
Journal	Voprosy onkologii (Vopr Onkol) Vol. 47 Issue 1 Pg. 49-51 ( 2001) ISSN: 0507-3758 [Print] Russia (Federation)
Vernacular Title	Zlokachestvennye opukholi tsentral'noĭ nervnoĭ sistemy mogut byt' dostupny dlia ataki spetsificheskimi antitelami.
PMID	11317535 (Publication Type: English Abstract, Journal Article)
Chemical References	Antibodies, Neoplasm Immunoglobulin G Fluorescein-5-isothiocyanate
Topics	Antibodies, Neoplasm (therapeutic use) Blotting, Western Brain Neoplasms (immunology, therapy) Fluorescein-5-isothiocyanate Glioma (immunology, therapy) Humans Immunoglobulin G (therapeutic use) Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!